Trending...
- Sairahaz Highlights Moissanite Wedding Rings as Couples Seek Value and Individuality in 2026
- Sundar Ramayya and Sulekha Ramayya of EvolveNXT named EY US Entrepreneur Of The Year
- Awepra Continues National Expansion Through Content, Community, and Professional Experiences
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Californer -- The ROS1ders is pleased to issue their inaugural Request for Application (RFA) to study ROS1-positive (ROS1+) cancer.
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to improve quality of life and survival for all patients with this disease."
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
More on The Californer
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 31, 2023. A subset of those applicants will be invited to submit a full application due June 15, 2023. Award recipients will be announced in late summer. For more information, visit https://theros1ders.org/seed-grant-program.
More on The Californer
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to improve quality of life and survival for all patients with this disease."
The ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree and a faculty appointment at an academic or non-profit research institution anywhere in the world.
More on The Californer
- California: Governor Newsom, Legislative leaders announce 2026-27 balanced budget agreement that ensures $0 deficit, while funding healthcare and key services
- California: El Gobernador Newsom y Líderes Legislativos anuncian un acuerdo sobre el presupuesto equilibrado para 2026-27 que asegura $0 déficit, mientras sigue financiando la atención médica y servicios esenciales
- Beach Streets Returns to Downtown Long Beach to Celebrate Global Soccer on July 19
- Festival of AAPI Books Returns to Long Beach Public Library with Day of Stories, Culture and Community
- Student Filmmaker Brayden Zachow Completes Short Film "The 8th & 9th Step"
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 31, 2023. A subset of those applicants will be invited to submit a full application due June 15, 2023. Award recipients will be announced in late summer. For more information, visit https://theros1ders.org/seed-grant-program.
More on The Californer
- California celebrates nearly 3.5 billion universal school meals served
- THE DASH CAM: THINKWARE Launches Fourth of July and Canada Day Deals
- Governor Newsom signs executive order to accelerate new technologies and services for California's local transit and passenger rail networks throughout the state
- For International Joke Day: Gotta Tickle Your Funny Bone? Check out "Crazy Robert's Joke Book"
- Senco Home Services Expands Residential Construction Services
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
Source: The ROS1ders, Inc.
Filed Under: Health, Non-profit
0 Comments
Latest on The Californer
- Governor Newsom announces $227 million to combat illicit cannabis activity and protect California communities
- Verbica Challenges Panetta to a Televised Debate on the Issues
- Salt Lake City Families Turn to Private Autopsy Services for Faster Answers After Unexpected Loss
- K2 Integrity's U.S. and EMEA Teams Again Recognized in Chambers and Partners 2026 Guides
- California becomes the first state to launch a tool to monitor and track artificial intelligence's impacts on the workforce
- Connecta Satellite Solutions Ready to Support Emergency Communications Following the Venezuela Earthquake
- Rare 1933 Harold Weston painting will be auctioned to benefit the Keene Valley Library
- $20 Million Revenue Target, Accelerating Growth, 7% Of Outstanding Shares Retired, Clear Path Toward Profitability: VSee Health, Inc N A S D A Q: VSEE
- RadioMobile Announces Sponsorship of the Burn Institute's Firefighter Demolition Derby & Fire & Safety Expo
- What If Creativity Is Your Natural State? "The Spark Sessions" Reclaims It as a Birthright
- HomeCentris Home Health Achieves 5-Star CMS Rating
- gptmelo Helps Brands Become More Visible in AI Search Results
- Shabnam Vafaee & Peter Sharokhi's Dream of helping people
- California: What they're saying: Leaders thankful for continued resources to help Los Angeles fire survivors
- Senior Technology Launches on iOS and Android
- Patchdesign.ai Launches First AI-Powered Platform to Deliver Custom Patches Worldwide in 10 Days
- California's earthquake warning system notified over one million people ahead of Northern California quake
- Adsoptia Launches AI-Powered Optimization Platform for a New Era of Autonomous Marketing Decisions
- California: Governor Newsom welcomes FEMA extension to help Los Angeles fire survivors continue recovery
- KooLooAI Selected Among Top 100 Companies in Pepperdine University's 2026 Most Fundable Companies®